Zobrazeno 1 - 10 of 114 pro vyhledávání: '"Hwa YL"'
1
Akademický článek
Retreatment of Multiple Myeloma with Previously Refractory Drugs.
Autor: Goel U; Mayo Clinic, United States., Charalampous C; Mayo Clinic, Rochester, Minnesota, United States., Kapoor P; Mayo Clinic, Rochester, MN, Rochester, Minnesota, United States., Binder M; Mayo Clinic, Rochester, Minnesota, United States., Buadi FK; Mayo clinic, Rochester, Minnesota, United States., Dingli D; Mayo Clinic, Rochester, Minnesota, United States., Dispenzieri A; Mayo Clinic, Rochester, Minnesota, United States., Fonder AL; Mayo Clinic, Rochester, Minnesota, United States., Gertz MA; Mayo Clinic, Rochester, Minnesota, United States., Gonsalves WI; Mayo Clinic, Rochester, Minnesota, United States., Hayman SR; Mayo Clinic, Rochester, Minnesota, United States., Hobbs MA; Mayo Clinic, Rochester, Minnesota, United States., Hwa YL; Mayo Clinic, Rochester, Minnesota, United States., Kourelis TV; Mayo Clinic, Rochester, Minnesota, United States., Lacy MQ; Mayo Clinic, Rochester, Minnesota, United States., Leung N; Mayo Clinic, Rochester, Minnesota, United States., Lin Y; Mayo Clinic, Rochester, Minnesota, United States., Warsame R; Mayo Clinic, Rochester, Minnesota, United States., Kyle RA; Mayo Clinic, Rochester, Minnesota, United States., Rajkumar SV; Mayo Clinic, Rochester, Minnesota, United States., Kumar SK; Mayo Clinic, Rochester, Minnesota, United States.
Publikováno v: Blood advances [Blood Adv] 2024 Nov 13. Date of Electronic Publication: 2024 Nov 13.
Zobrazit plný text záznamu
2
Akademický článek
Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies.
Autor: Charalampous C; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Goel U; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Kapoor P; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Binder M; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Buadi F; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Dingli D; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Dispenzieri A; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Fonder A; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Gertz M; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Gonsalves W; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Hayman S; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Hobbs M; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Hwa YL; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Kourelis T; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Lacy M; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Leung N; Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN., Lin Y; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Warsame R; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Kyle RA; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Rajkumar V; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN., Kumar SK; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN. Electronic address: kumar.shaji@mayo.edu.
Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Oct; Vol. 24 (10), pp. e329-e335. Date of Electronic Publication: 2024 Jun 01.
Zobrazit plný text záznamu
3
Correction: Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment.
Autor: Claveau JS; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Murray DL; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Department of Laboratory, Mayo Clinic, Rochester, MN, USA., Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Binder M; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Buadi F; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Fonder A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Gertz M; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Gonsalves W; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hayman S; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hobbs M; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hwa YL; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kourelis T; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lacy M; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Leung N; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Warsame R; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rajkumar V; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN, USA. Kumar.Shaji@mayo.edu.
Publikováno v: Leukemia [Leukemia] 2024 Aug; Vol. 38 (8), pp. 1863.
Zobrazit plný text záznamu
4
Editorial & Opinion
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures.
Autor: Zanwar S; Division of Hematology, Mayo Clinic, Rochester, MN, US., Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, US., Muchtar E; Division of Hematology, Mayo Clinic, Rochester, MN, US., Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN, US., Kourelis T; Division of Hematology, Mayo Clinic, Rochester, MN, US., Gonsalves W; Division of Hematology, Mayo Clinic, Rochester, MN, US., Go RS; Division of Hematology, Mayo Clinic, Rochester, MN, US., Hayman S; Division of Hematology, Mayo Clinic, Rochester, MN, US., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, US., Binder M; Division of Hematology, Mayo Clinic, Rochester, MN, US., Cook J; Division of Hematology, Mayo Clinic, Rochester, MN, US., Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN, US., Leung N; Division of Hematology, Mayo Clinic, Rochester, MN, US., Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, US., Warsame R; Division of Hematology, Mayo Clinic, Rochester, MN, US., Fonder A; Division of Hematology, Mayo Clinic, Rochester, MN, US., Hobbs M; Division of Hematology, Mayo Clinic, Rochester, MN, US., Hwa YL; Division of Hematology, Mayo Clinic, Rochester, MN, US., Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, US., Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, US., Kumar S; Division of Hematology, Mayo Clinic, Rochester, MN, US., Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, US. dispenzieri.angela@mayo.edu.
Publikováno v: Leukemia [Leukemia] 2024 Jun; Vol. 38 (6), pp. 1423-1426. Date of Electronic Publication: 2024 Apr 09.
Zobrazit plný text záznamu
5
Akademický článek
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
Autor: Goel U; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA., Charalampous C; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Binder M; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Fonder A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Gonsalves WI; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hayman SR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hobbs MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hwa YL; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kourelis T; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Leung N; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Warsame RM; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN, USA. Kumar.Shaji@mayo.edu.
Publikováno v: Blood cancer journal [Blood Cancer J] 2024 Mar 26; Vol. 14 (1), pp. 55. Date of Electronic Publication: 2024 Mar 26.
Zobrazit plný text záznamu
6
Akademický článek
Muscle and fat composition in patients with newly diagnosed multiple myeloma.
Autor: Abdallah NH; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Nagayama H; Division of Radiology, Mayo Clinic, Rochester, MN, USA., Takahashi N; Division of Radiology, Mayo Clinic, Rochester, MN, USA., Gonsalves W; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Fonder A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hobbs M; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Binder M; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Warsame R; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hayman SR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kourelis T; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hwa YL; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Broski SM; Division of Radiology, Mayo Clinic, Rochester, MN, USA., Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN, USA. kumar.shaji@mayo.edu.
Publikováno v: Blood cancer journal [Blood Cancer J] 2023 Dec 12; Vol. 13 (1), pp. 185. Date of Electronic Publication: 2023 Dec 12.
Zobrazit plný text záznamu
7
Editorial & Opinion
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
Autor: Charalampous C; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Goel U; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Kapoor P; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Binder M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Buadi FK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Cook J; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Dingli D; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Dispenzieri A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Fonder AL; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Gertz MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Gonsalves W; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Hayman SR; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Hobbs MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Hwa YL; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Kourelis T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Lacy MQ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Leung N; Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Lin Y; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Warsame R; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Kyle RA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Kumar SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. kumar.shaji@mayo.edu.
Publikováno v: Blood cancer journal [Blood Cancer J] 2023 Dec 11; Vol. 13 (1), pp. 183. Date of Electronic Publication: 2023 Dec 11.
Zobrazit plný text záznamu
8
Akademický článek
The impact of Post-Transplant doxycycline in AL amyloidosis - updated results after Long-Term follow up.
Autor: Abdallah N; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Muchtar E; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hwa YL; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Fonder A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hobbs MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hayman SR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Leung N; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Division of Nephrology, Mayo Clinic, Rochester, MN, USA., Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Go RS; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Gonsalves WI; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Binder M; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kourelis T; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Warsame R; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Publikováno v: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2023 Sep; Vol. 30 (3), pp. 261-267. Date of Electronic Publication: 2022 Dec 19.
Zobrazit plný text záznamu
9
Akademický článek
Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy.
Autor: Charalampous C; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Goel U; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Kapoor P; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Binder M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Buadi FK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Cook J; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Dingli D; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Dispenzieri A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Fonder AL; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Gertz MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Gonsalves W; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Hayman SR; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Hobbs MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Hwa YL; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Kourelis T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Lacy MQ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Leung N; Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Lin Y; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Warsame R; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Kyle RA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Kumar SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Publikováno v: Blood advances [Blood Adv] 2023 Aug 22; Vol. 7 (16), pp. 4371-4380.
Zobrazit plný text záznamu
10
Akademický článek
Conditional survival in multiple myeloma and impact of prognostic factors over time.
Autor: Abdallah NH; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Smith AN; Department of biostatistics, Mayo Clinic, Rochester, MN, USA., Geyer S; Department of biostatistics, Mayo Clinic, Rochester, MN, USA., Binder M; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Greipp PT; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Baughn LB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hayman SR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hwa YL; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kourelis T; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Warsame R; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN, USA. kumar.shaji@mayo.edu.
Publikováno v: Blood cancer journal [Blood Cancer J] 2023 May 15; Vol. 13 (1), pp. 78. Date of Electronic Publication: 2023 May 15.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje